CTRI/2019/04/018444已完成未知
To Evaluate Dermatological Safety of Investigational Products by 24 Hours Patch Test Under Complete Occlusion on Adult Healthy Human Subjects with Non-Sensitive and Sensitive Skin
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Healthy male and female subjects (1:1 ratio) in the age group of 18-65 years (both age inclusive) with non-sensitive skin
- •2. Subjects scoring more than 30 for Section 2- Sensitive v/s Resistant skin in modified Dr. Baumannâ??s skin type questionnaire. Please see detail annexure II
- •3. Subjects representing with normal, oily, dry and combination skin type in equal ratio.
- •4. Subjects with normal Fitzpatrick skin type III to V.
- •5. Female subjects with child bearing potential willing to undergo Urine Pregnancy Test.
- •5. Subjects free from excessive hair, cuts, wounds, irritation symptoms, abrasion or any other skin condition which may interfere in the study results.
- •6. Subjects willing to give voluntary written informed consent.
- •7. Subjects willing to maintain the patch test in position for 24 hours.
- •8. Subject having not participated in a similar investigation in the past two weeks.
- •9. Subjects willing to come for regular follow up visits.
- •10. Subjects ready to follow instructions during the study period.
排除标准
- •1. Infection, allergy on the tested area.
- •2. Skin allergy antecedents or atopic subjects.
- •3. Subjects with known hypersensitivity to any of the study products or constituents.
- •4. Subjects with any significant skin pathology in the investigational area
- •5. Athletes and subjects with history of excessive sweating.
- •6. Cutaneous disease which may influence the study result.
- •7. Subjects using any topical or systemic treatment that could interfere with the study treatments/assessments within the last 4 weeks prior to participation in the study and during the study.
- •8. Subjects on oral corticosteroid
- •9. Subjects participating in any other cosmetic or therapeutic study.
- •10. Female subjects who are pregnant or lactating.
- •11. Any history of underlying uncontrolled medical illness including diabetes, liver disease or history of alcoholism, HIV or any other serious medical illness.
研究者
相似试验
尚未招募
不适用
Primary Irritation Patch Test on Humans with Normal Skin TypeCTRI/2020/05/025311Dabur India Limited
已完成
不适用
Skin Safety study on Healthy human subjects with non-sensitive skiCTRI/2019/04/018464Dabur India Limited24
尚未招募
不适用
Skin Safety study on Healthy Human Subjects of all types SkiCTRI/2019/05/019100Dabur India Limited
已完成
不适用
To know the safety of Investigational products by assessing the irritation after patch application on healthy human volunteersCTRI/2013/01/003326ITC RD CENTRE24
已完成
不适用
To know the safety of Investigational products by assessing the irritation after patch application onhealthy human volunteersCTRI/2012/12/003246ITC RD CENTRE24
